+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy

Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy

Haematologica 84(3): 281-283

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 046973979

Download citation: RISBibTeXText

PMID: 10189399

Related references

The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkin's lymphoma patients. Advances in Clinical Pathology 6(1): 11-16, 2002

Characteristics of peripheral blood stem cell pbsc subpopulations in patients pts undergoing high dose chemotherapy hdc and pbsc support steady state ss collections versus chemotherapy ct mobilization. Proceedings of the American Association for Cancer Research Annual Meeting 31: 173, 1990

Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplantation 36(12): 1077-1082, 2005

Long term follow up in relapsed Hodgkin's disease (HD): Updated results of the HD-R1 study comparing conventional chemotherapy (cCT) to high-dose chemotherapy (HDCT) with autologous haemopoetic stem cell transplantation (ASCT) of the German Hodgkin Study Group (GHSG) and the Working Party Lymphoma of the European Group for Blood and Marrow Transplantation (EBMT). Journal of Clinical Oncology 23(16_Suppl): 6508-6508, 2016

Single center experience with Dexa-BEAM followed by autologous PBSC or BM transplantation for relapsed and resistant Hodgkin and non-Hodgkin lymphoma. Annals of Hematology 73(Suppl. 2): A110, 1996

Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. Leukemia and Lymphoma 51(11): 2012-2020, 2010

The high-dose sequential (Milan) chemotherapy/PBSC transplantation regimen for patients with lymphoma is not cardiotoxic. Annals of Oncology 10(5): 533-537, 1999

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation. Cancer 116(21): 5001-5011, 2010

Prognostic value of positron emission tomography (PET) scan in patients with relapsed Hodgkin lymphoma or aggressive Non-Hodgkin lymphoma receiving salvage chemotherapy followed by reduced-intensity allogeneic stem cell transplantation. 2007

Non-Hodgkin's lymphoma: Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplantation 30(2): 103-111, 2002

Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 113(23): 6011-6014, 2009

Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV). Leukemia and Lymphoma 40(5-6): 499-509, 2001

Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplantation 21(6): 607-614, 1998

Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report. Acta Haematologica 115(1-2): 15-21, 2006

The use of metaphors in non-Hodgkin's lymphoma patients undergoing chemotherapy. Journal of Advanced Nursing 74(11): 2622-2629, 2018